Cell-free Protein Expression Market 2022 : Most Demand Accounted for By Academic & Research Institutes

Cell-free bio-manufacturing is particularly well-suited for vaccine production due to its potential for rapid scale-up in response to public health emergencies. Successful cell-free expression of a number of recombinant vaccines, such as botulinum, diphtheria, anthrax, and others, have been developed and validated in animal models, such as mice.

Request For Free Sample Report of "Cell-free Protein Expression Market"@ https://www.persistencemarketresearch.com/samples/12385

In a recent study by Persistence Market Research on the global cell-free protein expression market, it is predicted that the market will grow from US$ 224.7 Mn in 2022 to over US$ 409 Mn by 2032, witnessing high growth of around 6.2% CAGR over the forecast period (2022-2032).

The simple presentation of cell-free protein expression systems makes it easier to integrate them into high-throughput platforms for efficient biologics and proteomics studies. Cell-free protein expression systems, being open systems, allow the addition of various natural and unnatural components to the reaction mixture, such as reducing/oxidizing elements, chaperones, labeled amino acids, or detergents, making this an appropriate choice for different proteomics studies. An increasing number of proteomics and biologics study programs is also expected to boost demand for cell-free protein expression systems.

Increasing expenditure on biosimilar development across the globe and rising application of cell-free protein expression systems in biosimilar research & development is projected to drive market growth over the coming years.

Key Takeaways from Market Study

The E.coli cell-free protein expression systems product segment accounted for the largest share of 48.2% in 2021.
The protein purification application segment held nearly one-third of the global market share in the year 2021.
With over 70% of global revenue share, continuous flow expression dominated the market in 2021.
Amongst the end users, academic and research institutes took the largest bid capturing nearly 44.4% of the market share by revenue globally in 2021.
North America held more than half of the revenue share in the global market in 2021.

"Cell-free protein expression market to witness significant growth owing to growing demand for continuous-exchange cell-free protein synthesis, vaccine production, and production of membrane proteins," says a Persistence Market Research analyst

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/12385

Who is Winning?

Some of the leading manufacturers of cell-free protein expression systems are ThermoFisher Scientific, Inc., Takara Bio Company, and Promega Corporation, who are solely focusing on collaborations and partnerships to provide data solutions to a large group of consumers in order to increase revenues across geographies.

In July 2021, Thermo Fisher Scientific announced a collaboration with Ortho Clinical Diagnostics.

In January 2020, ERS Genomics announced an agreement with New England Biolabs® to commercialize CRISPR gene editing tools and reagents.

In September 2018, Takara Bio Inc. announced that it entered into a license and supply agreement, through which it granted Daiichi Sankyo Co., Ltd with a commercial license to use applicable patents relating to RetroNectin*1 and also supply RetroNectin products.

Want More insights?

Persistence Market Research offers a unique perspective and actionable insights on the cell-free protein expression market in its latest study, presenting historical demand assessment of 2017 - 2021 and projections for 2022 - 2032

The research study is based on product (E.coli cell-free protein expression systems, rabbit reticulocytes cell-free protein expression systems, wheat germ cell-free protein expression systems, insect cells cell-free protein expression systems, and mammalian cell-free protein expression systems), application (enzyme engineering, protein labelling, protein-protein interaction, and protein purification), expression mode (continuous flow expression and batch expression), and end user (biotechnological companies, pharmaceutical companies, contract research organizations, and academic and research institutes) across seven key regions of the world.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/12385

Key Questions Answered in This Report.

What are the Roadblocks for Cell-free Protein Expression Market Suppliers?
What are the Key Opportunities for Cell-free Protein Expression Market Manufacturers?
How is Focus on Safety Influencing Cell-free Protein Expression Market Demand?
What is the Regulatory Impact on Global Sales of Cell-free Protein Expression Market?
Which Region Offers the Largest Opportunity for Sales of Cell-free Protein Expression Market?
Where Does the U.S. Stand in the Market for Cell-free Protein Expression Market?
What Is the Outlook for Cell-free Protein Expression Market Manufacturers in China?
Why is Germany a Lucrative Market for Cell-free Protein Expression Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Cell-free Protein Expression Market?
Why is There High Demand for Tires in Cell-free Protein Expression Market?
Why are Sales of Cell-free Protein Expression Market Surging?

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.